Sort   by:  
 Page size 

Hepatocellular carcinoma (HCC) is a highly aggressive form of carcinoma with a poor prognosis. Diagnostic markers and potential therapeutic targets for HCC are urgently needed. Here, we demonstrate that fecal microbiota transplantation (FMT) using stool samples from HCC patients significantly pro...

2025-12-05 | MTBLS12398 | MetaboLights
Targeted protein degradation is a modality based on small molecules that induce proximity between a protein of interest (POI) and an E3 ubiquitin ligase, thus prompting POI ubiquitination and degradation. To expand the reach of TPD, current research is geared to unlock novel E3s. To that end, the tr...
ORGANISM(S): Homo sapiens (Human) 
2024-01-08 | PXD040570 | Pride
Distal enhancers characterized by H3K4me1 mark play critical roles in developmental and transcriptional programs. However, potential roles of specific distal regulatory elements in regulating RNA Polymerase II (Pol II) promoter-proximal pause release remain poorly investigated. Here we report that a...
ORGANISM(S): Homo sapiens 
P53-P21-RB pathway promotes BRD4 degradation in liver cancer through decreasing USP1 transcription
BET bromodomain 2 inhibition couples chromatin displacement to SPOP-mediated BRD4/BRD4-NUT degradation, defining a therapeutic vulnerability in NUT carcinoma [CUT&RUN]
BET bromodomain 2 inhibition couples chromatin displacement to SPOP-mediated BRD4/BRD4-NUT degradation, defining a therapeutic vulnerability in NUT carcinoma [RNA-Seq]
Genomics
BRD4 degradation in CSCs
BRD4-NUT megadomains is an order of magnitude larger than super-enhancer regions and displays a more continuously enriched profile rather than appearing as a cluster of individual peaks. Chip-seq mapping of active chromatin marks in BRD4-NUT and different NMC cells
ORGANISM(S): Homo sapiens 
Sort   by:  
 Page size